Gregory.....so whats suppose to be bad here? first, I have no clue where your getting they will have to pay off PAR if they want to partner Rexista. now thats crazy talk...if they were partnered with PAR for Rexista why was the comapny saying they are looking for a partner? as for the reason not dilute. I point you to look at the balance sheet. unless they have some unforeseen expense they have plenty of capital to get through the rest of the year. expenses run roughly 3 million a quarter and they have 5.5 million in cash and equivleants and are expecting around 2 million in payments from PAR for Focalin for the rest of the year.. next?
There are numerous companies investigating or planning to investigate a variety of proposed anti-scarring therapies in clinical trials.
The companies include large and small pharmaceutical, chemical and biotechnology companies, as well as universities, government agencies and other private and public research organizations.
Such companies include Renovo Group plc, CoDa Therapeutics, Inc., Sirnaomics, Inc., FirstString Research, Inc., Merz Pharmaceuticals, LLC, Capstone Therapeutics, Halscion, Inc., Garnet Bio Therapeutics, Inc., AkPharma Inc., Promedior, Inc., Kissei Pharmaceutical Co., Ltd., Eyegene, Derma Sciences, Inc., Healthpoint Biotherapeutics, FibroGen, Inc. and Pharmaxon. In particular, Excaliard Pharmaceuticals, Inc., which has been acquired by Pfizer, Inc., has successfully advanced an anti-CTGF antisense oligonucleotide through several Phase 1 and Phase 2 trials and has demonstrated improved scar outcome over placebo.
Other companies working in the RNAi area, generally, include Alnylam Pharmaceuticals, Inc., Marina Biotech, Inc., Tacere Therapeutics, Inc., Benitec Limited, Silence Therapeutics plc, Quark..
Sentiment: Strong Sell
may be, but the sell off is going to be bigger..want to lose 50% to make 100%?
Sentiment: Strong Sell
In a way kinda agree with all the posts. I posted earlier that it was a nice spike in pps, but not to excited about it because volume was still a bit low, well now that volume has picked up, I wonder if the upcoming confrence is looming in a buy signal..GLTA Longs...
Yep up to my fixed quarterly unit amount to add. As I posted before, I have no intention of changing the fixed unit quarterly puchase. Low maintenance. I think MMLP has an auto reinvestment program. I don't use that since my unit investment each quarter stays constant and only the cash coming into my pocket or out of my pocket varies based upon the unit price at the time of my quarterly add. If the unit price goes too high and corrresponding yield too low I may skip a quarterly reinvestment and double up the unit purchase in a subsequent quarter. That is really the only decision I have to make. At lower pices the reinvestment is automatic
Its all about tax deferred yield and cash flow for me.
Aaron was elected almost exactly a year a go. board of Hawaii’s Better Business Bureau (BBB),
Sentiment: Strong Buy
We are stuck with a moronic imposter "4 r n e" who posts nonsense every 6 months then goes away. Silly man. The original was a flamboyant guy, the imposter is a grammatically challenged moron. Come back!
im712 • Mar 22, 2013 7:55 AM Flag
1users liked this postsusers disliked this posts0Reply
I now hold 250,000 shares. I started buying immediately after the sale-off subsequent to the January 30th launch. I did extensive research on the BlackBerry 10 Platform and Blackberry Z10 and Q10. We have a winning formula and we having even started yet. The new PlayBook is going to shock and awe when it's launch later this year - IMHO. Less
as usual, nope.
from the ask ubuntu page:
"Ubuntu 64 Bit - A LOT! (Actually 2^64) but because of hardware limits and real world computers the limit is around 1TB ( 1024GB RAM)"
you just enjoy making folks with a clue laugh.
and of course we love laughing at you too.
that's the power you have ; the power to unintentionally entertain.
And, with this as a backdrop, we learn today that security officers at a school in Minnesota refuse to allow the father of a student entry to the school because he was an Army Officer and in uniform, and it might offend someone.
$2.20 to $2.40 seems reasonable target if they hit $32MM in revs and can hit .12-.13 earnings... The timeframe between last divvy announcement & July earnings was really strong, so was last sept/oct